AMN Healthcare Services Inc: Form 10-K for the period ended Dec 31, 2013
Filed with the SEC on Feb 21, 2014 and accepted by EDGAR at Feb 21, 2014, 16:28 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-10-01 to 2013-12-31 | $248.7m | us-gaap:Revenues |
| Revenue | 12 months2013-01-01 to 2013-12-31 | $1.01bn | us-gaap:Revenues |
| Cost of revenue | 12 months2013-01-01 to 2013-12-31 | $714.5m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2013-10-01 to 2013-12-31 | $74.2m | us-gaap:GrossProfit |
| Gross profit | 12 months2013-01-01 to 2013-12-31 | $297.3m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2013-01-01 to 2013-12-31 | $218.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2013-01-01 to 2013-12-31 | $65.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2013-01-01 to 2013-12-31 | $9.7m | us-gaap:InterestExpense |
| Income tax | 12 months2013-01-01 to 2013-12-31 | $22.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2013-01-01 to 2013-12-31 | $32.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2013-01-01 to 2013-12-31 | $0.69 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2013-01-01 to 2013-12-31 | $0.72 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2013-01-01 to 2013-12-31 | 47,787,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2013-01-01 to 2013-12-31 | $58.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2013-01-01 to 2013-12-31 | $9.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2013-12-31 | $15.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-12-31 | $230.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-12-31 | $592.2m | us-gaap:Assets |
| Current liabilities | At period end2013-12-31 | $140.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-12-31 | $374.5m | us-gaap:Liabilities |
| Long-term debt | At period end2013-12-31 | $148.7m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2013-12-31 | $10.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2013-12-31 | $217.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001142750-14-000003. Last ingested by Listed: Nov 5, 2026, 17:59 ET. Listed shows no prices and gives no investment advice.